Turning Point Therapeutics, Inc.

TPTXDelisted Aug 17, 2022

Industry: Pharmaceutical Preparations
SEC CIK: 0001595893

SEC filings (opens in a new tab)

Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Turning Point Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of TPTX: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Of which not filed for Q3 2021	Q3 2021	Change
Holders	190	3	191	+4
Shares	46.0M	1.09M	44.8M	−32.1K (−0.1%)
Value	$3.59B	$85.0M	$2.98B	−$516.6M (−14.8%)

3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Turning Point Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to TPTX in Q3 2021
Institution	Shares	Value	% of portfolio
Pictet Asset Management SA	1,181,822	$78.5M	0.09%
Boxer Capital, LLC	525,000	$34.9M	1.22%
Ameriprise Financial Inc	119,914	$7.97M	0.00%
Congress Asset Management Co	34,635	$2.30M	0.02%
Twinbeech Capital LP	18,039	$1.20M	0.08%
Virginia Retirement Systems Et Al	11,100	$737.0K	0.01%
Engineers Gate Manager LP	10,435	$693.0K	0.04%
Dynamic Technology Lab Private Ltd	9,815	$652.0K	0.08%
HN Saltoro Capital, LP	9,000	$598.0K	0.48%
Fox Run Management, L.L.C.	8,944	$594.0K	0.37%
AQR Capital Management LLC	7,779	$517.0K	0.00%
Blueshift Asset Management, LLC	6,822	$453.0K	0.03%
PDT Partners, LLC	6,591	$438.0K	0.03%
Janus Henderson Group PLC	4,130	$275.0K	0.00%
Franklin Resources Inc	3,300	$219.0K	0.00%
Squarepoint Ops LLC	3,155	$210.0K	0.00%
Acadian Asset Management LLC	520	$34.0K	0.00%
Manchester Capital Management LLC	195	$13.0K	0.00%
Dark Forest Capital Management LP	54	$4.00K	0.00%
Parallel Advisors, LLC	48	$3.00K	0.00%
Bell Investment Advisors, Inc	19	$1.00K	0.00%
Carroll Financial Associates, Inc.	6	$0	0.00%
Berman Capital Advisors, LLC	12	$0	0.00%
Meridian Wealth Partners, LLC	2	$0	0.00%

Sold out (20)

Institutions that held Turning Point Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of TPTX in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Farallon Capital Management, L.L.C.	465,000	$36.3M
Logos Global Management LP	400,000	$31.2M
Renaissance Technologies LLC	142,700	$11.1M
Suvretta Capital Management, LLC	122,994	$9.60M
Casdin Capital, LLC	75,000	$5.85M
Balyasny Asset Management LLC	43,550	$3.40M
Sivik Global Healthcare LLC	30,000	$2.34M
Magnetar Financial LLC	6,059	$473.0K
Caxton Associates LP	4,931	$385.0K
Vontobel Holding Ltd.	4,762	$372.0K
Legato Capital Management LLC	3,647	$285.0K
Stonnington Group, LLC	3,100	$222.0K
Burrage Capital Management LLC	2,164	$169.0K
FORA Capital, LLC	907	$71.0K
Lazard Asset Management LLC	792	$61.0K
Neo Ivy Capital Management	372	$29.0K
Advisory Services Network, LLC	10	$1.00K
Rockefeller Capital Management L.P.	17	$1.00K
Bartlett & Co. Wealth Management LLC	3	$234
Bartlett & Co. LLC	3	$0

Not filed for Q3 2021 yet (3)

Institutions that held Turning Point Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TPTX in Q2 2021 that haven't filed for Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Pictet Asset Management Ltd	1,085,793	$84.7M
QS Investors, LLC	3,300	$258.0K
CWM, LLC	4	$0